Healio4 小时
Challenging cornea cases may require complex treatment course
OSN, a roundtable discusses the management of epithelial ingrowth after LASIK, neurotrophic keratitis and Demodex blepharitis with marginal keratitis.A few thoughts after decades of treating these ...
Aurion Biotech Pursues IPO For Cornea Disease Treatments
Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...